3 results match your criteria: "Hospital Universitario y Politécnico La Fe (HULAFE)[Affiliation]"
Repeated intravenous doses of human umbilical cord-derived mesenchymal stromal cells for bronchopulmonary dysplasia: results of a phase 1 clinical trial with 2-year follow-up.
Cytotherapy
June 2024
Pediatric Cardiology, Hospital Universitario Ramón y Cajal, Madrid and Instituto Ramón y Cajal de Investigación Sanitaria (IRyCIS), Madrid, Spain.
Background: Currently, there is a lack of effective treatments or preventive strategies for bronchopulmonary dysplasia (BPD). Pre-clinical studies with mesenchymal stromal cells (MSCs) have yielded encouraging results. The safety of administering repeated intravenous doses of umbilical cord tissue-derived mesenchymal stromal cells (UC-MSCs) has not yet been tested in extremely-low-gestational-age newborns (ELGANs).
View Article and Find Full Text PDFEffect of autologous umbilical cord blood transfusion in the development of retinopathy of prematurity: randomized clinical trial - study protocol.
Front Pediatr
October 2023
Department of Neonatology, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain.
Background: Currently, the treatment of anemia in preterm infants is based on packed red blood cell (RBC) transfusions from adult donors. Oxygen (O2) is mainly transported to the tissues bound to hemoglobin (Hb). In extremely low gestational age neonates (ELGANs), fetal hemoglobin (HbF), which has a higher affinity for O2, represents up to 95% of circulating hemoglobin.
View Article and Find Full Text PDFGeneral approach to delivery and resuscitation of newborn infants from mothers at risk or proven COVID-19.
Semin Fetal Neonatal Med
April 2023
Division of Neonatology, Hospital Universitario y Politécnico La Fe (HULAFE), Valencia, Spain; Instituto de Investigación en Salud La Fe (IISLAFE), Valencia, Spain. Electronic address: